Cancer Mortality-China, 2018

Yunning Liu(刘韫宁), Wei Wang(王薇), Jiangmei Liu(刘江美), Peng Yin(殷鹏),

 Jinlei Qi(齐金蕾), Jinling You(由金玲), Lijun Wang(王黎君), Maigeng Zhou(周脉耕)

Abstract

Introduction

Cancer  is  an  important  public  health concern with heavy disease burden in China. In 2017, cancer is the leading cause of death, with around 2.60 million  deaths,  which  accounts  for  26.07% of  all deaths. This study aims to present cancer mortality in China in 2018 to provide evidence for cancer control and prevention.

Methods

Mortality data from China Cause of Death Reporting  System  (CDRS)  and  population  data  from National  Bureau  of  Statistics  are  used  for  cancer mortality  estimation.  A  descriptive  analysis  was conducted to demonstrate the results.

Results

A  total  of  2,557,297  cancer  deaths  were estimated in China in 2018 with a mortality rate and age-standardized  mortality  rate  of  183.89  and  145.60 per  100,000,  respectively.  Lung,  liver,  and  stomach cancer  were  the  three  leading  causes  of  cancer  death and accounted for around 56.75% of all cancer deaths.The age-standardized mortality rate was higher in men(194.37  per  100,000)  than  in  women  (99.47  per

100,000), in urban areas (148.25 per 100,000) than in rural  areas  (144.62  per  100,000),  and  in  eastern regions (150.57 per 100,000) than in central (142.09 per  100,000)/western  regions  (141.54  per  100,000).The  age-specific  mortality  rate  remains  low  for  the population  younger  than  44  years  old  and  reaches  its peak after 80 years old. Leukemia is the leading cause of cancer death among those aged 0–14 years in both sexes, while breast cancer is the leading cause of cancer death in women aged 15–44 years.

Conclusions and Implications for Public Health

Practice The cancer mortality patterns show substantial disparities among sexes, age groups, areas, and regions.Healthy lifestyle promotion, active vaccination uptake,and  environmental  governance  are  essential  to eliminate  cancer-related  risk  factors  in  the  overall population.  Tailored  strategies  for  the  early  screening and diagnosis, therapeutic management, and palliative care  should  be  a  top  priority  for  enforcement  among